FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for risperidone (RISPERDAL) from Janssen Pharmaceuticals, Inc., resulting in changes to its labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperdal (risperidone)

Snippet

SUPPL AP for RISPERDAL (RISPERIDONE)